Suppr超能文献

多药耐药基因mdr1、mdr3和mrp在对核糖核苷酸还原酶抑制剂耐药的L1210白血病细胞中的过表达。

Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase.

作者信息

Rappa G, Lorico A, Liu M C, Kruh G D, Cory A H, Cory J G, Sartorelli A C

机构信息

Department of Pharmacology and Developmental Therapeutics Program, Cancer Center, Yale University School of Medicine, New Haven, CT, 06520, U.S.A.

出版信息

Biochem Pharmacol. 1997 Sep 15;54(6):649-55. doi: 10.1016/s0006-2952(97)00210-4.

Abstract

L1210 MQ-580 is a murine leukemia cell line resistant to the cytotoxic activity of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone class of inhibitors of ribonucleotide reductase. The line is cross-resistant to etoposide, daunomycin, and vinblastine. L1210 MQ-580 cells expressed 8-fold resistance to 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP), a relatively newly developed inhibitor of ribonucleotide reductase. The accumulation of [14C]3-AP by L1210 MQ-580 cells was 5- to 6-fold less than by parental L1210 cells. An increased rate of efflux of 3-AP was responsible for the lower steady-state concentration of 3-AP in resistant cells. In reverse transcription-polymerase chain reaction assays, L1210 MQ-580 cells were found to overexpress the multidrug resistance genes mdr1, mdr3, and mrp, but not the mdr2 gene, compared with parental L1210 cells. Measurement of the steady-state concentration of doxorubicin, a potential substrate for both the mdr and mrp gene products, demonstrated that L1210 MQ-580 cells accumulated 4-fold less anthracycline than parental cells. These findings indicate that drug efflux is a major determinant of the pattern of cross-resistance of L1210 MQ-580 cells. To extrapolate these observations to the human homologues of the mdr1, mdr3, and mrp murine genes, the effects of 3-AP were measured in L1210/VMDRC0.06 and NIH3T3 36-8-32 cells transfected with human MDR1 and MRP cDNAs, respectively. The transfectants were 2- to 3-fold resistant to the cytotoxic effects of 3-AP and accumulated less [14C]3-AP than their parental mock-transfected counterparts. Moreover, the cytotoxic activity of 3-AP was significantly greater in two double mrp gene knockout cell lines than in parental W 9.5 embryonic stem cells. Thus, the results suggest that 3-AP is a substrate for both the P-glycoprotein and MRP and that baseline MRP expression has the capacity to exert a protective role against the toxicity of this agent.

摘要

L1210 MQ - 580是一种对核糖核苷酸还原酶α-(N)-杂环羧醛硫代半卡巴腙类抑制剂的细胞毒性活性具有抗性的小鼠白血病细胞系。该细胞系对依托泊苷、柔红霉素和长春碱具有交叉抗性。L1210 MQ - 580细胞对3 - 氨基吡啶 - 2 - 羧醛硫代半卡巴腙(3 - AP)表现出8倍的抗性,3 - AP是一种相对新开发的核糖核苷酸还原酶抑制剂。L1210 MQ - 580细胞对[14C]3 - AP的摄取量比亲代L1210细胞少5至6倍。3 - AP流出速率的增加导致抗性细胞中3 - AP的稳态浓度降低。在逆转录 - 聚合酶链反应分析中,发现与亲代L1210细胞相比,L1210 MQ - 580细胞中多药耐药基因mdr1、mdr3和mrp过表达,但mdr2基因未过表达。对阿霉素(一种mdr和mrp基因产物的潜在底物)稳态浓度的测量表明,L1210 MQ - 580细胞中蒽环类药物的积累量比亲代细胞少4倍。这些发现表明药物流出是L1210 MQ - 580细胞交叉抗性模式的主要决定因素。为了将这些观察结果外推至mdr1、mdr3和mrp小鼠基因的人类同源物,分别在转染了人类MDR1和MRP cDNA的L1210/VMDRC0.06和NIH3T3 36 - 8 - 32细胞中测量了3 - AP的作用。转染细胞对3 - AP的细胞毒性作用具有2至3倍的抗性,并且比其亲代mock转染细胞积累的[14C]3 - AP更少。此外,在两个双mrp基因敲除细胞系中,3 - AP的细胞毒性活性比亲代W 9.5胚胎干细胞中的显著更大。因此,结果表明3 - AP是P - 糖蛋白和MRP的底物,并且基线MRP表达具有对该药物毒性发挥保护作用的能力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验